By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Vermillion this week said that it will work with reimbursement services firm Premiere Source Diagnostics for the OVA1 triage ovarian cancer test.

In addition, the firm said that the US Bankruptcy Court in Delaware has approved the final fee application in its Chapter 11 reorganization case. The total professional fees and expenses were about $3.8 million, of which $2.7 million remained unpaid as of March 31.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Germany's Project DEAL has come to an agreement with the publisher Wiley over journal access and open-access publishing, ScienceInsider reports.

A Canadian panel recommends public coverage of the gene therapy Kymriah if its cost comes down, the Globe and Mail reports.

Researchers uncover additional loci associated with lifespan, which the Telegraph says could be folded into a genetic test.

In Nucleic Acids Research this week: new accurate quantification by sequencing approach, CNV breakpoints in Plasmodium falciparum, and more.